It has been postulated that HLA-G may interact with unknown protein partners in tumor cells to activate the STAT3 pathway (41), but this study actually identifies a contemporary HLA-G binding partner with respect to its activation of the STAT3 pathway. Here, STAT3 is linked to neoplasm.